Endocrinology Physician
Form Health is a virtual obesity medicine clinic delivering multi-disciplinary evidence-based obesity treatment through telemedicine. Obesity impacts more than 40% of the US adult population, and although historically only about 1% of patients received medical treatment for their disease, the field of Obesity Medicine is entering a period of rapid growth. Form Health provides high-quality expert care and leverages technology to enhance the patient experience. All Form Health patients work closely with their physician-led care team, which also includes advanced practice professionals and Registered Dietitians. Through our proprietary mobile app patients engage in regular video visits, as well as text messaging, photo journaling, digital data transmission, and customized educational materials. We hold ourselves to the highest standards of clinical care, and to treating every individual with empathy and respect.
Founded in 2019, Form Health is a venture-backed innovative startup with an experienced clinical and leadership team. Our mission is to empower patients and be leaders in Obesity Medicine driving impact at a national scale. We are deeply invested in our core value to put patients first, and also deeply committed to creating a culture where every employee is valued and we learn and improve together.
About the Role:
We are seeking Physicians specialized in Endocrinology and Obesity Medicine to join our innovative, multidisciplinary chronic disease management team. A valid medical license to practice and prescribe legally in any US state is required, and eligibility to obtain additional state licenses as needed is required.
This role is designed for an American Board of Internal Medicine (ABIM) certified Endocrinologist with demonstrated expertise in obesity medicine, comprehensive diabetes management, and a strong interest in working collaboratively with Endocrine Advanced Practice Providers (APPs) in providing high-quality patient care.
A critical aspect of this role is ensuring the safe and effective management of patients with complex co-morbidities, including Chronic Kidney Disease (CKD), End-Stage Renal Disease (ESRD), and Cardiovascular conditions. The physician will help enhance the consistency, safety, and effectiveness of patient care across the team, specifically integrating the use of Continuous Glucose Monitors (CGMs) and insulin pump therapy.
This is a fully remote W-2 position (US-based), with flexible scheduling options: 32 total hours per week, 36 total hours per week, or 40 total hours per week. From the total working hours, 80% will be clinical/patient-facing care, and 20% administrative time.
What You Will Do:
- Provide direct patient care in a telemedicine clinical setting, focusing on evidence-based treatment for obesity and comprehensive diabetes management, including insulin titration and care of patients who may already be using insulin pumps and/or continuous glucose monitors (CGMs)
- The role could involve having your own panel of patients, or collaborating with APPs and Registered Dietitians specializing in diabetes treatment, primarily Type 2 Diabetes. This role could involve APP collaboration and supervision, as needed
- Review charts and conduct initial and return visits to ensure quality, continuity of care, and appropriate management of CKD/ESRD and CAD/CV conditions
- Provide advanced treatment planning and medical management support for complex endocrinology cases, escalated concerns, and patients requiring specialized management protocols.
- Prescribe non-controlled medications, including those for obesity and diabetes, for patients under both direct care and in coordination with APPs
- Ensure clinical documentation, protocols, and treatment pathways are followed consistently within the team, with a focus on guidelines for managing complex diabetic populations
- Assist in the professional development of colleagues by fostering clinical growth, offering feedback, and support
Get remote healthcare jobs like this by email
One weekly digest. No spam, unsubscribe anytime.